Insider Selling: CryoPort (NASDAQ:CYRX) CFO Sells $300,312.00 in Stock

CryoPort, Inc. (NASDAQ:CYRX) CFO Robert Stefanovich sold 38,700 shares of the stock in a transaction dated Thursday, March 12th. The shares were sold at an average price of $7.76, for a total transaction of $300,312.00. Following the completion of the transaction, the chief financial officer directly owned 255,701 shares in the company, valued at approximately $1,984,239.76. This represents a 13.15% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.

Robert Stefanovich also recently made the following trade(s):

• On Monday, March 16th, Robert Stefanovich sold 2,743 shares of CryoPort stock. The stock was sold at an average price of $8.00, for a total value of $21,944.00.

CryoPort Trading Down 2.9%

CryoPort stock opened at $8.12 on Thursday. The company has a market capitalization of $404.86 million, a price-to-earnings ratio of 6.15 and a beta of 1.69. CryoPort, Inc. has a 12 month low of $4.63 and a 12 month high of $11.45. The stock’s 50 day moving average is $9.14 and its 200-day moving average is $9.35.

CryoPort (NASDAQ:CYRX) last released its quarterly earnings results on Tuesday, March 3rd. The company reported ($0.21) earnings per share for the quarter, missing the consensus estimate of ($0.19) by ($0.02). The firm had revenue of $45.45 million for the quarter, compared to analyst estimates of $42.92 million. CryoPort had a negative return on equity of 8.22% and a net margin of 42.35%. As a group, equities research analysts predict that CryoPort, Inc. will post -0.99 earnings per share for the current fiscal year.

Analyst Ratings Changes

CYRX has been the subject of a number of recent research reports. Wall Street Zen cut shares of CryoPort from a “hold” rating to a “sell” rating in a research report on Saturday, March 7th. Weiss Ratings reiterated a “sell (d+)” rating on shares of CryoPort in a research note on Monday, December 29th. Finally, Needham & Company LLC boosted their price objective on shares of CryoPort from $12.00 to $13.00 and gave the company a “buy” rating in a report on Wednesday, March 4th. Eight research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, CryoPort currently has an average rating of “Moderate Buy” and a consensus price target of $12.94.

Institutional Trading of CryoPort

A number of institutional investors have recently modified their holdings of the stock. Basepoint Wealth LLC acquired a new stake in shares of CryoPort during the 4th quarter worth $34,000. Tower Research Capital LLC TRC raised its stake in CryoPort by 300.1% in the second quarter. Tower Research Capital LLC TRC now owns 5,833 shares of the company’s stock valued at $44,000 after purchasing an additional 4,375 shares in the last quarter. Whittier Trust Co. of Nevada Inc. acquired a new position in CryoPort in the third quarter valued at about $53,000. ProShare Advisors LLC bought a new stake in CryoPort during the second quarter worth about $75,000. Finally, AlphaQuest LLC bought a new stake in CryoPort during the third quarter worth about $79,000. 92.90% of the stock is currently owned by institutional investors.

CryoPort Company Profile

CryoPort, Inc (NASDAQ: CYRX) is a global provider of temperature-controlled logistics solutions for the life sciences industry. The company specializes in cryogenic shipping for critical biological materials, supporting the development, clinical testing and commercialization of cell and gene therapies, biologics, vaccines and reproductive medicine. By offering end-to-end supply chain management, CryoPort helps ensure the integrity and viability of temperature-sensitive products from point of origin to destination.

CryoPort’s product portfolio includes proprietary cryogenic dry shippers, advanced active and passive thermal packaging, and real-time data monitoring platforms.